Cancer drug maker takes sudden pivot into crypto
-
最新报道：MAIA Biotechnology (NYSE: MAIA) has allocated up to 90% of its liquid assets into cryptocurrencies like Bitcoin, Ethereum, and USD Coin, causing its stock to surge over 8% intraday to $1.89. CEO Vlad Vitoc stated the strategy aims to diversify the portfolio with high-quality tokens for strong returns while maintaining cancer research focus. The firm will establish a Digital Assets Advisory Board to oversee transactions and cybersecurity.
下一篇
Kyle Samani says Solana was the 'always the answer' for new crypto treasury venture
- Multicoin Capital co-founder Kyle Samani said the firm's launch of Solana-based treasury c...
24小时热点
热点专题
407106